Eravacycline Overview

Reviewed: December 17, 2014

Eravacycline is an antibiotic under development for the treatment of multidrug-resistant (MDR) infections, including those caused by MDR Gram-negative bacteria. Eravacycline is a novel, fully synthetic tetracycline antibiotic. It is a broad-spectrum intravenous and oral antibiotic.

Tetraphase Pharmaceuticals is currently investigating the safety and efficacy of eravacycline in a Phase 3 program called IGNITE (Investigating Gram-negative Infections Treated with Eravacycline) for the treatment of complicated intra-abdominal infections (cIAI)(IGNITE 1) and complicated urinary tract infections (cUTI)(IGNITE 2). The company expects to file for U.S. regulatory approval for eravacycline for both indications by the end of 2015.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Eravacycline Brand Names

Eravacycline may be found in some form under the following brand names:

Eravacycline Drug Class

Eravacycline is part of the drug class:


All RxWiki content including health news, medication pages, and condition pages published prior to February 2023, was written and maintained by on-staff pharmacists. Please be advised that this content is no longer actively maintained and may now contain outdated information. If you have any questions regarding previously published content, please contact